Orthofix Medical (OFIX) director buys 5,000 common shares

Rhea-AI Filing Summary

Orthofix Medical Inc. director Vickie L. Capps bought a total of 5,000 shares of common stock in open-market transactions. The purchases occurred on March 9–10, 2026 at prices around $12.44–$12.48 per share. Following these trades, she directly holds 27,585 shares, which include 21,934 previously reported deferred stock units and 651 shares acquired under Orthofix's stock purchase plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CAPPS VICKIE L

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TX 75056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		P		2,500	A	$12.48	25,085(1)	D
Common Stock	03/10/2026		P		100	A	$12.44	25,185(1)	D
Common Stock	03/10/2026		P		2,400	A	$12.45	27,585(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 21,934 previously reported deferred stock units and 651 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

	/s/ J. Andres Cedron, Attorney-in-fact	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider buying did Orthofix Medical (OFIX) disclose in this Form 4?

Orthofix Medical disclosed that director Vickie L. Capps bought 5,000 common shares. She completed open-market purchases on March 9–10, 2026 at prices between $12.44 and $12.48 per share, increasing her direct ownership stake in Orthofix Medical.

At what prices did Vickie L. Capps buy Orthofix Medical (OFIX) shares?

Capps bought Orthofix Medical shares at about $12.44–$12.48 each. Individual trades were reported at $12.48 for 2,500 shares, $12.45 for 2,400 shares, and $12.44 for 100 shares, all classified as open-market purchases of common stock.

How many Orthofix Medical (OFIX) shares does Vickie L. Capps own after these trades?

After these transactions, Capps directly holds 27,585 Orthofix shares. This total includes 21,934 previously reported deferred stock units and 651 shares acquired under Orthofix's stock purchase plan, as noted in the footnote to the filing.

What types of securities did Vickie L. Capps acquire in Orthofix Medical (OFIX)?

Capps acquired Orthofix Medical common stock through open-market purchases. The filing also explains that her reported direct holdings include deferred stock units and shares obtained under Orthofix's stock purchase plan, but the new transactions themselves were all in common stock.

Does the Orthofix Medical (OFIX) Form 4 mention any special plan treatment for certain shares?

Yes, the Form 4 notes shares from Orthofix's Stock Purchase Plan. It states 651 shares were acquired under the plan, which qualifies as a “Stock Purchase Plan” under Rule 16b-3(b)(5), making those acquisitions exempt from Section 16(b) short-swing profit rules.